Donald A. Bergstrom - 28 Jul 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
President, R&D
Signature
/s/ Brian Adams, as Attorney-in-Fact
Issuer symbol
RLAY
Transactions as of
28 Jul 2025
Transactions value $
-$113,478
Form type
4
Filing time
30 Jul 2025, 16:54:05 UTC
Previous filing
30 Apr 2025
Next filing
30 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bergstrom Donald A President, R&D C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE /s/ Brian Adams, as Attorney-in-Fact 30 Jul 2025 0001709772

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$15.2K -4.07K -0.7% $3.74 579K 28 Jul 2025 Direct F1, F2
transaction RLAY Common Stock Sale -$98.3K -26.7K -4.61% $3.68 553K 29 Jul 2025 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 9,072 shares of restricted stock units ("RSUs") on July 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 297,038 shares underlying RSUs.
F3 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 59,550 shares of RSUs on July 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F4 Includes 237,488 shares underlying RSUs.